Testifying before the US Senate Subcommittee on Antitrust, Competition Policy and Consumer Rights, government attorney William Baer said the deal is “a game-changer that demands merger law enforcement officials to scrutinize very, very carefully to make sure we aren’t making a mistake in which shareholders benefit and the consumers pay the cost.” Baer is assistant attorney general in the US Department of Justice Antitrust Division.
Humana and Aetna are pursuing a merger at the same time as two other huge, national health insurance companies: Anthem and Cigna.
Regulators have been closely scrutinizing both deals, because their completion could reduce the number of big players in the health insurance industry from five to three.
“Whenever you have two major transactions in an already concentrated industry occurring roughly at the same time, one needs to look at the interaction between two transactions and look down the road,” Baer said. “It also affects one’s view of whether or not one or both transactions are really fixable.”
Humana agreed in July to be acquired by Aetna for $37 billion in a deal that would create the second-largest managed-care company in the United States.
Full Content: The Business Journals
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Court Order Temporarily Halts U.S. Consumer Financial Protection Bureau Layoffs
Feb 16, 2025 by
CPI
Nokia Poised to Gain EU Approval for $2.3 Billion Infinera Acquisition
Feb 16, 2025 by
CPI
Turkey Fines Frito-Lay in Antitrust Crackdown
Feb 16, 2025 by
CPI
Advances Bill to Strengthen Antitrust Enforcement Through AI
Feb 16, 2025 by
CPI
Intel Faces Potential Breakup as Broadcom and TSMC Explore Deals
Feb 16, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Criminal Enforcement
Jan 23, 2025 by
CPI
The Antitrust Division’s Recent Work to Combat International Cartels
Jan 23, 2025 by
Emma Burnham & Benjamin Christenson
Information Sharing: The New Frontier of U.S. Antitrust Enforcement
Jan 23, 2025 by
Brian P. Quinn, Casey Kovarik & Michael Tubach
The Key Role of Guidelines on Exchanges of Information Among Competitors and the Divergent Transatlantic Paths
Jan 23, 2025 by
Rosa Abrantes-Metz & Albert Metz
Leniency, Whistleblowers, and Compliance
Jan 23, 2025 by
Richard Powers, Tara O’Malley & Cory Gordon